Synopsis：Dulutevir sodium salt is the second generation of HIV-1 integrase chain transfer inhibitor. Dulutevir sodium salt is currently in phase III clinical trials for the treatment of HIV infection. Dulutvir sodium salt has been shown to effectively inhibit HIV replication in cells infected with self inactivated Phiv lentivirus vectors, such as peripheral blood monocytes (PBMC), MT-4 cells and CIP4 cells.
Structural formula:
Properties
Summary
Dulutevir sodium salt is the second generation of HIV-1 integrase chain transfer inhibitor. Dulutevir sodium salt is currently in phase III clinical trials for the treatment of HIV infection. Dulutvir sodium salt has been shown to effectively inhibit HIV replication in cells infected with self inactivated Phiv lentivirus vectors, such as peripheral blood monocytes (PBMC), MT-4 cells and CIP4 cells.
CDMO
